{"id":"https://openalex.org/W2335198060","doi":"https://doi.org/10.1158/1538-7445.am2011-778","title":"Abstract 778: Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation","display_name":"Abstract 778: Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2335198060","doi":"https://doi.org/10.1158/1538-7445.am2011-778","mag":"2335198060"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-778","doi":"https://doi.org/10.1158/1538-7445.am2011-778","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-778","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008824892","display_name":"Justin Paul Kline","orcid":"https://orcid.org/0000-0002-2967-6448","observed_orcids":["https://orcid.org/0000-0002-2967-6448"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin P. Kline","raw_affiliation_strings":["1University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100363498","display_name":"Long Zhang","orcid":"https://orcid.org/0000-0001-8139-0474","observed_orcids":["https://orcid.org/0000-0001-8139-0474","https://orcid.org/0000-0002-5125-0224","https://orcid.org/0009-0001-9526-3836"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Long Zhang","raw_affiliation_strings":["1University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025658340","display_name":"Kenneth Stuart Cohen","orcid":"https://orcid.org/0000-0002-6291-273X","observed_orcids":["https://orcid.org/0000-0002-6291-273X"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Cohen","raw_affiliation_strings":["1University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085317448","display_name":"Thomas Frank Gajewski","orcid":"https://orcid.org/0000-0001-5727-3972","observed_orcids":["https://orcid.org/0000-0001-5727-3972"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas F. Gajewski","raw_affiliation_strings":["1University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"778","last_page":"778"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6557999849319458,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6557999849319458,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.31299999356269836,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.025699999183416367,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.8899999856948853},{"id":"https://openalex.org/keywords/tumor-rejection","display_name":"tumor rejection","score":0.8009999990463257},{"id":"https://openalex.org/keywords/treg-depletion","display_name":"Treg depletion","score":0.9480000138282776},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/cd4-t-cell-help","display_name":"CD4+ T cell help","score":0.7350000143051147},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.7789999842643738},{"id":"https://openalex.org/keywords/b7-costimulation","display_name":"B7 costimulation","score":0.9729999899864197},{"id":"https://openalex.org/keywords/cd40-ligand","display_name":"CD40 ligand","score":0.7910000085830688},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9760000109672546},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9819999933242798},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/perforin","display_name":"perforin","score":0.7229999899864197},{"id":"https://openalex.org/keywords/fas-ligand","display_name":"Fas ligand","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.7341703176498413},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5784463286399841},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.5712618827819824},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.5628507733345032},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.5571484565734863},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5365673899650574},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48288440704345703},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.45795002579689026},{"id":"https://openalex.org/C2779234475","wikidata":"https://www.wikidata.org/wiki/Q14897851","display_name":"CD154","level":5,"score":0.45064836740493774},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.44096148014068604},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.422377347946167},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4005979895591736},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3821718692779541},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3773716986179352},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.29110288619995117},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07380086183547974},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-778","doi":"https://doi.org/10.1158/1538-7445.am2011-778","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-778","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2538149674","https://openalex.org/W1982529683","https://openalex.org/W2113315096","https://openalex.org/W1975987206","https://openalex.org/W2115408190","https://openalex.org/W2497555399","https://openalex.org/W2051218772","https://openalex.org/W2002809032","https://openalex.org/W2257930088","https://openalex.org/W766574906"],"abstract_inverted_index":{"Abstract":[0],"We":[1],"have":[2],"recently":[3],"demonstrated":[4],"that":[5,112,168,258,317,363],"adoptive":[6,393],"transfer":[7,150,394],"of":[8,24,57,72,126,136,151,171,188,234,244,251,286,291,356,374,387,412,417],"regulatory":[9],"T":[10,15,43,60,73,98,103,117,129,137,154,160,173,192,215,263,296,309,347,358,381],"cell":[11,99,138,382],"(Treg)":[12],"-depleted":[13],"polyclonal":[14],"cells":[16,44,61,74,77,104,118,130,155,161,174,180,216,231,264,272,297,310,319,362],"into":[17,162],"lymphopenic":[18],"mice":[19,92,95,306],"can":[20,320],"result":[21],"in":[22,45,63,86,144,274,280,305,312,336,384],"rejection":[23,40,82,142,223],"B16":[25,202,220,230,301,318],"melanoma.":[26],"In":[27,238],"the":[28,33,54,169,205,385,402,413,418],"current":[29],"work,":[30],"we":[31,110,246],"investigated":[32],"cellular":[34],"and":[35,69,115,148,184,194,200,229,253,289,314,342,376],"molecular":[36],"requirements":[37],"for":[38,121,219,369,399,421],"tumor":[39,66,81,141,255,269,277,282,339,370],"by":[41,75,210,261,268,293],"CD25-depleted":[42,97,295,308],"RAG\u2212/\u2212":[46],"or":[47,93,107,213,328],"irradiated":[48,87,145],"C57BL/6":[49],"recipient":[50],"mice.":[51],"Consistent":[52],"with":[53,149,157,350],"robust":[55],"expansion":[56],"antigen-specific":[58],"CD8+":[59,116,159,191,212,346],"observed":[62,111],"this":[64],"model,":[65],"antigen":[67,340],"cross-presentation":[68,341],"B7":[70,343],"costimulation":[71,344],"host":[76,228,240,338],"was":[78,175,217,224,298],"required,":[79],"as":[80,352],"did":[83],"not":[84,176,185],"occur":[85],"Kb\u2212/\u2212":[88],"bone":[89],"marrow":[90],"chimeric":[91],"B71/2\u2212/\u2212":[94],"following":[96],"transfer.":[100],"Using":[101],"donor":[102],"from":[105],"CD4\u2212/\u2212":[106],"CD8\u2212/\u2212":[108],"mice,":[109],"both":[113,227],"CD4+":[114,128,172,214,357],"were":[119,232],"necessary":[120],"B16.SIY":[122],"rejection.":[123,283],"The":[124,372],"contribution":[125],"conventional":[127],"led":[131],"us":[132],"to":[133,177,190,197,345,401],"investigate":[134],"mechanisms":[135],"help.":[139],"Interestingly,":[140],"occurred":[143],"CD40\u2212/\u2212":[146],"hosts,":[147],"IL2\u2212/\u2212":[152],"CD4+CD25\u2212":[153],"along":[156,349],"wildtype":[158],"RAG2\u2212/\u2212":[163],"hosts.":[164],"These":[165],"results":[166,332],"indicate":[167],"role":[170,355],"license":[178],"antigen-presenting":[179],"(APC)":[181],"through":[182,186,236,324],"CD40L,":[183],"provision":[187],"IL-2":[189],"cells,":[193,348,359],"may":[195],"be":[196,321],"directly":[198],"recognize":[199],"kill":[201],"cells.":[203],"At":[204],"effector":[206,361],"phase,":[207],"IFN-\u03b3":[208,259,368],"production":[209,285],"adoptively-transferred":[211,262,294],"sufficient":[218],"elimination.":[221],"Tumor":[222],"lost":[225],"when":[226],"incapable":[233],"signaling":[235],"IFN-\u03b3.":[237],"a":[239,334,388],"environment":[241],"completely":[242],"devoid":[243],"IFN-\u03b3,":[245],"found":[247],"decreased":[248],"intra-tumoral":[249],"expression":[250,267,290],"CXCL-10":[252,266],"increased":[254],"vascularity,":[256],"suggesting":[257],"produced":[260],"induced":[265],"and/or":[270],"stromal":[271],"which":[273,337],"turn,":[275],"inhibited":[276],"angiogenesis,":[278],"resulting":[279],"IFN-\u03b3-dependent":[281],"Finally,":[284],"TNF-\u03b1,":[287],"perforin":[288,313],"FasL":[292],"dispensable,":[299],"though":[300],"melanomas":[302],"grew":[303],"progressively":[304],"receiving":[307],"deficient":[311],"FasL,":[315],"arguing":[316],"killed":[322],"either":[323],"granule":[325],"mediated":[326],"lysis":[327],"apoptosis-induction.":[329],"Collectively,":[330],"these":[331],"support":[333],"model":[335],"an":[351],"yet":[353],"undefined":[354],"generate":[360],"depend":[364],"at":[365],"least":[366],"upon":[367],"control.":[371],"elimination":[373],"Tregs":[375],"homeostatic":[377],"proliferation":[378],"maintain":[379],"persistent":[380],"function":[383],"context":[386],"growing":[389],"tumor.":[390],"This":[391],"straightforward":[392],"strategy":[395],"has":[396],"strong":[397],"potential":[398],"translation":[400],"clinic.":[403],"Citation":[404],"Format:":[405],"{Authors}.":[406],"{Abstract":[407],"title}":[408],"[abstract].":[409],"In:":[410],"Proceedings":[411],"102nd":[414],"Annual":[415],"Meeting":[416],"American":[419],"Association":[420],"Cancer":[422,432],"Research;":[423],"2011":[424],"Apr":[425],"2-6;":[426],"Orlando,":[427],"FL.":[428],"Philadelphia":[429],"(PA):":[430],"AACR;":[431],"Res":[433],"2011;71(8":[434],"Suppl):Abstract":[435],"nr":[436],"778.":[437],"doi:10.1158/1538-7445.AM2011-778":[438]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2025-10-10T00:00:00"}